ACE-I induced angioedema: A case report and review of literature

Cases Journal

Volumn 2, Issue 7, 2009, Pages

  Adebayo, Philip Babatunde ^a   Alebiosu, Olutayo Christopher ^a  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CHLORPHENIRAMINE; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROCORTISONE; LISINOPRIL; PREDNISOLONE;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; FACE EDEMA; FOOT EDEMA; HEART DISEASE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; HYPERTENSIVE HEART DISEASE; MALE; MOUTH EDEMA; PAROXYSMAL DYSPNEA; PHARYNX DISEASE; PHYSICAL EXAMINATION;

EID: 77953452504     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-7181     Document Type: Article

References (15)

1. Cicardi M, Agostini A: Hereditary angioedema. N Engl J Med 1996, 334:1666-1667.
2. Quincke H: Uber akutes umschriebenes Hautodem. Monatsh Prakt Dermatol 1882, 1:129-131.
3. Morimoto T, Gandhi TK, Fiskio JM et al.: An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004, 10:499-509.
4. Sondhi D, Lippmann M, Murali G: Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest 2004, 126:400-404.
5. Sarkar P, Nicholson G, Hall G: Brief review: Angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anesth 2006, 53:994-1003.
6. Messerli FH, Nussberger J: Vasopeptidase inhibition and angiooedema. Lancet 2000, 356:608-609.
7. Wilkin JK, Hammond JJ, Kirkendall WM: The captopril-induced eruption: a possible mechanism: cutaneous kinin potentiation. Arch Dermatol 1980, 116:902-905.
8. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ: ACE inhibitor-induced angioedema: incidence, prevention and management. Drug Saf 1998, 18:171-188.
9. John BK, Harold JK, James R, Thomas C, Allen K, Jonathan C, Elliott : Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005, 165:1637-1642.
10. Kaplan AP, Joseph K, Silverberg M: Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 2002, 109:195-209.
11. Molinaro G, Cugno M, Perez M et al.: Angiotensin-converting enzyme inhibitor associated angioedema is characterized by a slower degradation of des-arginine (9)-bradykinin. J Pharmacol Exp Ther 2002, 303:232-237.
12. Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A: Aminopeptidase P in individuals with a history of angiooedema on ACE inhibitors. Lancet 2002, 359:2088-2089.
13. Nussberger J, Cugno M, Cicardi M: Bradykinin-mediated angioedema. N Engl J Med 2002, 347:621-622.
14. Orfan N, Patterson R, Dykewicz MS: Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. JAMA 1990, 264:1287-1289.
15. Agostoni A, Cicardi M: Contraindications to the use of ace inhibitors in patients with C1 esterase inhibitor deficiency [case reports]. Am J Med 1991, 90:278.